文献速递鼻科

复发性鼻出血30天再入院风险预测:RHINO-ooze评分的推导与验证

Recurrent epistaxis: predicting risk of 30-day readmission, derivation and validation of RHINO-ooze score.
PubMed 文献 · Rhinology · 2017-01-01

研究基于2013年10月至2014年9月收治的鼻出血患者回顾性数据推导出RHINO-ooze评分(满分8分,含5个变量),并在2014年10月至2015年10月的验证队列中检验。研究期内共834例入院;评分≥6分预测高风险患者30天再入院的敏感度为81%、特异度为84%。作者认为该工具可作为临床决策的辅助手段,用于把握手术干预时机以降低再入院率。

要点

  • RHINO-ooze评分由5个变量构成,最高8分。
  • 评分≥6分预测30天再入院的敏感度81%、特异度84%。
  • 推导队列与验证队列的30天再入院率相似。

核心结论

  • RHINO-ooze评分工具在预测鼻出血患者30天再入院风险方面显示出良好的特异度和敏感度,可作为临床决策的辅助手段,用于把握手术干预时机以降低再入院率。

研究设计与样本

  • 回顾性数据推导并验证预测评分模型:推导队列为2013年10月至2014年9月收治的鼻出血患者(n=302),验证队列为2014年10月至2015年10月收治的鼻出血患者,研究期内共834例入院。
  • 通过医学数据库检索影响复发性鼻出血的因素,并结合回顾性数据分析构建评分模型;采用后向消除法的多元线性回归推导预测模型,计算曲线下面积(AUC)、敏感度和特异度。

主要发现

  • 研究期内共834例入院。
  • 推导队列(n=302)建成RHINO-ooze评分,满分8分,含5个变量(近期入院、出血点未明确、年龄大于70岁且递增、后鼻孔填塞、口服抗凝药)。
  • RHINO-ooze评分的卡方值为99.72,显著性水平小于0.0001,模型整体拟合良好。
  • 推导组与验证组比较显示两队列30天再入院率相似。
  • 评分≥6分预测高风险复发性鼻出血患者30天再入院的敏感度为81%、特异度为84%。

关键数值与推荐

  • RHINO-ooze评分满分8分,由5个变量构成:近期入院、出血点未明确、年龄大于70岁且递增、后鼻孔填塞、口服抗凝药。
  • 高风险判定阈值为RHINO-ooze评分≥6分,该阈值预测30天再入院的敏感度81%、特异度84%。

临床怎么用

  • 作者认为该评分工具可作为临床决策的辅助手段,用于把握手术干预时机以降低再入院率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To derive and validate a predictive scoring tool (RHINO-ooze score) with good sensitivity and specificity in identifying patients with epistaxis at high risk of 30 day readmission and to enable risk stratification for possible definitive intervention. METHODS: Using medical databases, we searched for factors influencing recurrent epistaxis. The information ascertained together with our analysis of retrospective data on patients admitted with epistaxis between October 2013 and September 2014, was used as the derivation cohort to develop the predictive scoring model (RHINO-ooze score). The tool was validated by performing statistical analysis on the validation cohort of patients admitted with epistaxis between October 2014 and October 2015. Multiple linear regressions with backwards elimination was used to derive the predictive model. The area under the curve (AUC), sensitivity and specificity were calculated. RESULTS: 834 admissions were encountered within the study period. Using the derivative cohort (n= 302) the RHINO-ooze score with a maximum score of 8 from five variables (Recent admission, Haemorrhage point unidentified, Increasing age over 70, posterior Nasal packing, Oral anticoagulant) was developed. The RHINO-ooze score had a chi-square value of 99.72 with a significance level of smaller than 0.0001 and hence an overall good model fit. Comparison between the derivative and validation groups revealed similar rates of 30-day readmission between the cohorts. The sensitivity and specificity of predicting 30-day readmission in high risk patients with recurrent epistaxis (RHINO-ooze score equal/larger than 6) was 81% and 84%, respectively. CONCLUSIONS: The RHINO-ooze scoring tool demonstrates good specificity and sensitivity in predicting the risk of 30 day readmission in patients with epistaxis and can be used as an adjunct to clinical decision making with regards to timing of operative intervention in order to reduce readmission rates.

来源:Rhinology,查看原文。版权归原作者所有。

引用

  1. Addison A, Paul C, Kuo R, et al. Recurrent epistaxis: predicting risk of 30-day readmission, derivation and validation of RHINO-ooze score. Rhinology. 2017. PMID: 28434017. doi:10.4193/Rhin16.259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。